Combined segregation-linkage analysis of plasma thrombin activatable fibrinolysis inhibitor (TAFI) antigen levels with TAFI gene polymorphisms

[1]  L. Tiret,et al.  Identification of polymorphisms in the promoter and the 3' region of the TAFI gene: evidence that plasma TAFI antigen levels are strongly genetically controlled. , 2001, Blood.

[2]  R. Verkerk,et al.  Immunological Assay for the Determination of Procarboxypeptidase U Antigen Levels in Human Plasma , 2001, Thrombosis and Haemostasis.

[3]  L. Bajzar.  Thrombin Activatable Fibrinolysis Inhibitor and an Antifibrinolytic Pathway , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[4]  P. Reitsma,et al.  Identification of polymorphisms in the TAFI gene promoter: Relationship with plasma TAFI levels and risk of venous thrombosis. , 2000 .

[5]  A. Hamsten,et al.  Plasma Procarboxypeptidase U in Men with Symptomatic Coronary Artery Disease , 2000, Thrombosis and Haemostasis.

[6]  P. Morange,et al.  Thrombin-Activatable Fibrinolysis Inhibitor Antigen Levels and Cardiovascular Risk Factors , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[7]  P. Morange,et al.  Plasma TAFI Antigen Variations in Healthy Subjects , 2000, Thrombosis and Haemostasis.

[8]  F. Rosendaal,et al.  Thrombin activatable fibrinolysis inhibitor and the risk for deep vein thrombosis. , 2000, Blood.

[9]  P. Klement,et al.  A Novel Approach to Arterial Thrombolysis , 1999 .

[10]  A. Morioka,et al.  Arginine Carboxypeptidase (CPR) in Human Plasma Determined with Sandwich ELISA , 1999, Microbiology and immunology.

[11]  M. Boffa,et al.  Characterization of the gene encoding human TAFI (thrombin-activable fibrinolysis inhibitor; plasma procarboxypeptidase B). , 1999, Biochemistry.

[12]  M. Nagashima,et al.  Identification and Characterization of Two Thrombin-activatable Fibrinolysis Inhibitor Isoforms , 1998, Thrombosis and Haemostasis.

[13]  P. A. von dem Borne,et al.  Plasma TAFI Levels Influence the Clot Lysis Time in Healthy Individuals in the Presence of an Intact Intrinsic Pathway of Coagulation , 1998, Thrombosis and Haemostasis.

[14]  M. Boffa,et al.  A Study of the Mechanism of Inhibition of Fibrinolysis by Activated Thrombin-activable Fibrinolysis Inhibitor* , 1998, The Journal of Biological Chemistry.

[15]  C. Hack,et al.  Enhancement of rabbit jugular vein thrombolysis by neutralization of factor XI. In vivo evidence for a role of factor XI as an anti-fibrinolytic factor. , 1998, The Journal of clinical investigation.

[16]  E. Plow,et al.  On the Mechanism of the Antifibrinolytic Activity of Plasma Carboxypeptidase B* , 1997, The Journal of Biological Chemistry.

[17]  L. Tiret,et al.  Identification of new polymorphisms of the angiotensin I-converting enzyme (ACE) gene, and study of their relationship to plasma ACE levels by two-QTL segregation-linkage analysis. , 1996, American journal of human genetics.

[18]  L. Tiret,et al.  Testing for association between disease and linked marker loci: a log-linear-model analysis. , 1991, American journal of human genetics.

[19]  Shirley A. Miller,et al.  A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.

[20]  S. Zeger,et al.  Longitudinal data analysis using generalized linear models , 1986 .

[21]  A. Donner,et al.  A multivariate analysis of family data. , 1981, American journal of epidemiology.